Pirfenidone axunio (previously Pirfenidone AET) European Union - Norwegian - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Pirfenidone Viatris European Union - Norwegian - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Pirfenidone Sandoz 801 mg Norway - Norwegian - Statens legemiddelverk

pirfenidone sandoz 801 mg

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg

Pirfenidone Sandoz 267 mg Norway - Norwegian - Statens legemiddelverk

pirfenidone sandoz 267 mg

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg

Pirfenidone Newbury 267 mg Norway - Norwegian - Statens legemiddelverk

pirfenidone newbury 267 mg

newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 267 mg

Pirfenidone Newbury 801 mg Norway - Norwegian - Statens legemiddelverk

pirfenidone newbury 801 mg

newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 801 mg

Esbriet European Union - Norwegian - EMA (European Medicines Agency)

esbriet

roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

Ofev European Union - Norwegian - EMA (European Medicines Agency)

ofev

boehringer ingelheim international gmbh - nintedanib - idiopatisk lungefibrose - antineoplastiske midler - ofev er indisert hos voksne til behandling av idiopatisk lungfibrose (ipf).

Litfulo European Union - Norwegian - EMA (European Medicines Agency)

litfulo

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunsuppressive - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Ofev 150 mg Norway - Norwegian - Statens legemiddelverk

ofev 150 mg

orifarm as - nintedanib - kapsel, myk - 150 mg